AUM-003

N/A

Report date: 2024/12/16 13:24:22

NME

Base Information

Drug NameAUM-003

Drug Alias NameAUM-003

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors

TargetsMAP kinase-interacting serine/threonine-protein kinase MNK1MAP kinase-interacting serine/threonine-protein kinase 2

Therapy Area/IndicationsGlioblastomaSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAUM Biosciences Pte Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAUM Biosciences Pte Ltd

Inactive CompaniesN/A

Active IndicationsGlioblastomaSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A